POPULARITY
Categories
In this episode, we revisit the critical topic of America's pharmaceutical industry with Iowa Congresswoman Mariannette Miller-Meeks. Join us as we discuss the recent steps taken by President Trump to bring pharmaceutical manufacturing back to the U.S., the challenges of drug shortages, and the innovative measures being proposed to ensure a stable supply chain. Discover how regulatory relief, tax provisions, and the role of pharmacy benefit managers are shaping the future of pharmaceuticals in America. Next, we explore the urgent need for reshoring America's drug manufacturing with industry leaders David Shook and Craig Henahan. Discover the complexities of sourcing generic pharmaceuticals, the challenges posed by outsourcing, and the innovative solutions being developed to bring essential drug production back to the U.S. Finally, we welcome David Bozell, president of the Media Research Center, to discuss the current state of journalism in America. Together, we dissect recent controversial comments made by media figures and explore the implications of their rhetoric. David shares insights on how the media landscape has changed, particularly in the wake of political events and social tensions. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Thank you for tuning in for another episode of Life's Best Medicine. Dr. Ken Berry is a Fellow in The American Academy of Family Physicians and has been practicing Family Medicine in rural Tennessee for over a decade (having seen over 20,000 patients in his career so far). He is the author of the best selling book Lies My Doctor Told Me. He received his medical degree from University of Tennessee College of Medicine. In this episode, Drs. Brian and Ken talk about… (00:00) Intro (04:29) The multitude benefits of eating the proper human diet (11:25) The place of fruit and fiber in the proper human diet (14:44) The importance of getting your fasting insulin checked (20:31) Why LDL and Cholesterol are not the bad guys (23:42) How the entire field of medicine has been captured by big Pharma (31:08) The brain/body connection and how diet impacts mood and mental health (39:24) Whether meat is addictive (47:25) Why standards in the medical field are so slow to change (51:38) Thyroid issues and how the should be treated (55:08) Sex hormones (57:43) The spectrum of possible approaches to the proper human diet (01:02:20) Calcium (01:07:14) Outro For more information, please see the links below. Thank you for listening! Links: Dr. Ken Berry: Website Common Sense Labs Dr. Brian Lenzkes: Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/ Brain Bootcamp: https://prescott-now.com/event/brain-bootcamp-resource-event/ HLTH Code: HLTH Code Promo Code: METHEALTH HLTH Code Website: https://gethlth.com
Aging is more than disease—it's the steady decline of function. In this episode of Longevity by Design, Dr. Gil Blander speaks with physicist-turned-biotech innovator Dr. Peter Fedichev about why resilience, not diseases, holds the key to longer lives.Peter explains how his background in theoretical physics shaped his approach to biology and aging. He outlines why startups, not large institutions, are now leading innovation in longevity science. Drawing from physics, he describes aging as a series of “jumps” between states, each leaving the body more fragile.The discussion moves from the limits of current drugs to the promise of new approaches. Peter argues that reducing fluctuations and increasing molecular fidelity could unlock far greater gains in healthspan and lifespan. Listeners gain a fresh lens on what drives aging, where the real breakthroughs may come from, and why the next frontier in longevity will require rethinking the problem altogether. Guest-at-a-Glance
Andrew and Ben discuss the TikTok deal framework, pharma companies investing in the US, and a preview of the Fed meeting today. For information on how to join the Zoom calls live each morning at 8:30 EST, visit:https://www.narwhal.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhal.com/disclosure
Health Secretary Robert F. Kennedy Jr. has issued a report on the state of children's health.On Today's Show:Julie Rovner, chief Washington correspondent, KFF Health News and host of the What the Health? podcast, talks about the details of the report and where it fits into the Trump administration's MAHA initiative.
Sophie Sargent walked into the studio already owning the mic. A pandemic-era media rebel raised in New Hampshire, trained in Homeland Security (yep), and shaped by rejection, she's built a career out of DM'ing her way into rooms and then owning them. At 25, she's juggling chronic illness, chronic overachievement, and a generation that gets dismissed before it even speaks.We talk Lyme disease, Lyme denial, and the healthcare gaslighting that comes when you “look fine” but your body says otherwise. We dive into rejection as a career accelerant, mental health as content porn, and what it means to chase purpose without sacrificing identity. Sophie's a former morning radio host, country music interviewer, and Boston-based creator with a real voice—and she uses it.No fake podcast voice. No daddy-daughter moment. Just two loudmouths from different planets figuring out what it means to be seen, believed, and taken seriously in a system designed to do the opposite.Spoiler: She's smarter than I was at 25. And she'll probably be your boss someday.RELATED LINKSSophie on InstagramSophie on YouTubeSophie on LinkedInMedium article: “Redefining Rejection”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What happens when you hand a mic to the most extroverted, uncensored Gen Z career coach in New York? You get Olivia Battinelli—adjunct professor, student advisor, mentor, speaker, and unfiltered truth-teller on everything from invisible illness to resume crimes.We talked about growing up Jewish-Italian in Westchester, surviving the Big Four's corporate Kool-Aid, and quitting a job after 7 months because the shower goals weren't working out. She runs NYU Steinhardt's internship program by day, roasts Takis and “rate my professor” trolls by night, and somehow makes room for maple syrup takes, career coaching, and a boyfriend named Dom who sounds like a supporting character from The Sopranos.She teaches kids how to talk to humans. She's allergic to BS. And she might be the most Alexis Rose-meets-Maeve Wiley-mashup ever dropped into your feed. Welcome to her first podcast interview. It's pure gold.RELATED LINKS:Olivia Battinelli on LinkedInOlivia's Liv It Up Coaching WebsiteOlivia on InstagramNYU Steinhardt Faculty PageFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks
On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks
In the Season 3 finale, Pluri CEO Yaky Yanay joins Felicia Shakiba for a powerful conversation on leading transformation through trust, transparency, and bold vision. He shares how he redefined Pluri's identity—from pharma to cell-based tech innovator—while building a culture that puts people, purpose, and innovation first. A high-stakes, high-insight episode on what true leadership looks like in times of change. Chapters 00:00 The Importance of Culture in Leadership 12:11 Navigating Organizational Transformation 17:53 Overcoming Resistance to Change 26:47 Building Trust Through Transparency 31:05 Expanding Vision Without Losing Focus 36:45 Advice for Leaders in Times of Change
This week on the podcast, Heather and Matthew are joined by Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA), which represents the regulatory, legislative, and general business interests of Contract Development and Manufacturing Organizations (CDMOs) in the bio/pharma space. Gil shares how CDMOs are navigating regulatory uncertainty, the potential impact of tariffs on drug pricing and supply chains, and what recent executive orders could mean for innovation and access to care. Tune in now!
The Pharma boys break down Nashville's loss to FC Cincinnati at TQL stadium. They also break down a crazy MLS weekend and preview the US Open Cup semifinal against the Philadelphia Union.
I answered a lot of questions this weekend. But if you want to know what I'm doing with my money - JUST LISTEN. If you want more details, join the paid subscribers on the newsletter, but this podcast is more about teaching than it is following me. I know from the audience growth, the people who have purchased the tools and developed their own system - THIS WORKS! Here are the links to all the sales: TRENDSPIDER - The best charting software EVER - just over $50/month with my link
I'm excited to reshare one of our most-played conversations—the one where Norwegian regulator/HTA leader Anja Schiel and I get very practical about when single-arm trials fail decision-makers and what comparative, smarter alternatives look like for regulators, HTA bodies, payers, clinicians, and—most importantly—patients.
Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this Friday Headline Brief of The Wright Report, we cover new details on Charlie Kirk's assassination, major economic signals ahead of a Fed decision, Senate Republicans' “nuclear option” on confirmations, Trump's crackdown on drug ads, immigration fallout with South Korea, and global headlines from Sweden, Germany, and North Korea. Quick hits to set your radar for the weekend. Charlie Kirk's Final Flight and Killer Hunt: VP JD Vance escorted Kirk's body home on Air Force Two, calling him “a true friend” and vowing, “You ran a good race, my friend. We've got it from here.” Investigators recovered a Mauser rifle and cartridges allegedly marked with Antifa and transgender slogans. The assassin, still at large, is described as a man in his mid-20s. Economic Warning Lights: Producer inflation drops as businesses eat tariff costs, but jobless claims hit a four-year high. Analysts expect a quarter- to half-point Fed rate cut next week. Senate GOP Fast-Tracks Trump Nominees: Republicans changed rules to bypass Democrat obstruction, clearing the way for 150 stalled executive branch picks. Judicial nominees remain vulnerable to Democrat blockades. Trump Targets Big Pharma Ads: An executive order ends the 1997 loophole allowing short TV drug ads. Pharma may face five-minute disclosures, threatening billions in ad revenue for networks like CNN and Fox. Immigration Fallout with South Korea: Hyundai's Korean workers arrested in Georgia say they warned bosses their visas were illegal. Seoul warns investment may cool without faster visa reform, while Trump explores expedited paths for specialized labor. Sweden's Child Hitmen and Migrant Payoffs: Gangs recruit boys as young as 12 to kill, exploiting loopholes in juvenile law. Sweden will lower prosecution age and pay $34K per migrant to return home. Germany's Migrant Dilemma: Only 1,300 of 1 million Syrian migrants accepted $1,500 to leave. Meanwhile, 80,000 a year gain citizenship, fueling AfD's rise. North Korea Intrigue and U.S. Ops: Kim Jong Un parades his 12-year-old daughter as heir, though his son may be hidden abroad. A failed SEAL Team 6 mission six years ago revealed how close the U.S. came to planting a spy device inside North Korea. "And you shall know the truth, and the truth shall make you free." - John 8:32 Take your personal data back with Incogni! Get 60% off an annual plan at incogni.com/TWR and use code TWR at checkout. KKeywords: Charlie Kirk assassination updates, JD Vance tribute quote, Mauser rifle Antifa cartridges, U.S. producer inflation jobs Fed rate cut, Senate Republicans nuclear option confirmations, Trump Big Pharma ad executive order, Hyundai Korean workers Georgia raid, South Korea investment visa reform, Sweden migrant child hitmen gangs, Sweden $34K migrant return offer, Germany Syrian migrants AfD populist surge, Kim Jong Un daughter heir, North Korea SEAL Team 6 mission failed
Pharma ad crackdown, Murdoch succession, NFL streaming surge, EV ad spend, plus economy, 2030 ad trends, and Apple's latest showcase.Kate Scott-Dawkins and Jeff Foster unpack a busy week in advertising and media: the Trump administration's potential crackdown on pharma ads, the Murdoch family's succession deal, NFL's streaming surge from Brazil, and aggressive EV ad spending from Lucid, VinFast, and Chinese OEMs. Plus, a U.S. economy update, highlights from WPP's 2030 Advertising Futures report, and takeaways from Apple's latest showcase.Chapters:00:00 - Introduction & sports recap01:08 - U.S. economy: Inflation, jobs revisions, Fed outlook03:25 - Pharma ad crackdown & market impact06:00 - Murdoch succession & media strategy10:07 - NFL on YouTube TV: Brazil game success11:00 - Auto ad trends & EV newcomers13:13 - Advertising in 2030: WPP's extended-cut report17:15 - Apple tech showcase: Incremental updates19:10 - Wrap-up & next week's previewAdvertising in 2030 report: https://www.wppmedia.com/news/Latest-Advertising-in-2030?utm_source=MediaIntelligence&utm_medium=podcast&utm_content=ep75
In this episode of SCW for Pharma, host Evren Ozkaya welcomes Dexter Tjoa, CEO of Tjoapack, a global contract packaging organization with over three decades of experience in the pharmaceutical industry. Dexter shares his journey into pharma, beginning as a supply chain consultant with a background in mathematics, and later transitioning into the packaging and supply chain domain. He also reflects on leading a family business founded in 1989 and its evolution into a global player with operations in both Europe and the United States.The conversation explores Tjoapack's strategic expansion into the U.S. market, highlighting the drivers behind establishing a presence there and the broader implications of recent U.S. government policies and investments in domestic pharmaceutical manufacturing. Dexter emphasizes that while reshoring production is a growing theme, pharma remains inherently global, and companies must maintain an international perspective to ensure resilience and efficiency.Evren and Dexter then examine the role of contract packaging and manufacturing organizations in today's pharmaceutical supply chains. Dexter explains how CPOs and CDMOs allow pharma companies to leverage specialized expertise, often in areas that are difficult to replicate in-house. Some focus on niche production, such as targeted medicines or unique packaging solutions for oral solids—an area where Tjoapack has built strong capabilities. Beyond their specialization, CPOs and CDMOs can also drive cost efficiencies, particularly when they invest in automation, Pharma 4.0 technologies, and lean practices that reduce expenses, enhance quality, and ensure compliance in GMP-regulated environments. Dexter notes that the increasing complexity of the industry—fueled by smaller batch sizes and the rise of targeted therapies—is reshaping production dynamics and amplifying the need for flexible, high-skill partners.The discussion also addresses industry challenges, from labor shortages to the urgent need for flexible automation. Dexter highlights talent development as a top priority, sharing how Tjoapack redefined its training programs, improved transparency around career paths, and created a culture of meaningful work to attract and retain skilled employees. He stresses that automation alone is insufficient without investment in people, and that balancing both is critical for long-term success.On the digital transformation front, Dexter underscores the importance of paperless quality solutions, intelligent automation, and transparent data sharing across the pharma supply chain. He argues that shop floor automation can significantly reduce costs while improving quality. At the same time, integration and collaboration with partners through timely, transparent data exchange are essential for building resilient supply chains. In his view, digital transformation is no longer optional but essential for survival in an increasingly competitive CPO/CDMO market.The conversation concludes with reflections on leadership and personal advice. Dexter describes the evolving role of the CEO—from team-building and inspiration to digital leadership and execution—and offers guidance to younger generations entering pharma: embrace risk, stay open to learning, and move forward decisively even amid uncertainty.
Jordan Rubin - founder of Garden of Life and Ancient Nutrition - joins Dr. Will Cole for one of the most powerful episodes yet. From nearly dying of Crohn's disease to later facing terminal cancer, Jordan shares his extraordinary healing journey, the faith that sustained him, and the revelations that followed. Together they unpack his new book The Biblio Diet, including the overlooked power of “healing leaves,” the biblical superfoods most of us have gotten wrong, and why true healing requires more than just medicine. For all links mentioned in this episode, visit www.drwillcole.com/podcastPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:You can save 10% on your first order with the code willcole at check out. Just head to nansfoods.com.Save 30% off your first subscription order & receive a free six pack of Ketone-IQ with KETONE.com/WILLCOLE.MANUKORA.com/WILLCOLE to save 31% plus $25 worth of free gifts.Text ABW to 64000 to get twenty percent off all IQBAR products, plus FREE shipping. Message and data rates may apply.AG1 is offering new subscribers a FREE $76 gift when you sign up. You'll get a Welcome Kit, a bottle of D3K2 AND 5 free travel packs in your first box. So make sure to check out DrinkAG1.com/willcole to get this offer. Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Steve Liesman and Rick Santelli read the jobs and inflation data tea leaves ahead of next week's Fed decision. The executive order that could have a huge impact on US drugmakers. Plus, is $160 lipstick the key to jumpstarting the luxury trade?
TODAY ON THE ROBERT SCOTT BELL SHOW: MAHA Report Released, Trump "Limits" Pharma Ads, Cindy's Iron Question, Mephitis Putorius, Buried Vax-Unvax Study, Unvaccinated Kids Are Healthier, Test Scores Major Collapse, Doctors Group Abandons Ship and MORE! https://robertscottbell.com/maha-report-released-trump-limits-pharma-ads-cindys-iron-question-mephitis-putorius-buried-vax-unvax-study-unvaccinated-kids-are-healthier-test-scores-major-collapse-doctors-group/https://boxcast.tv/view/maha-report-released-trump-limits-pharma-ads-buried-vax-unvax-study-another-doctors-group-abandons-ship---the-rsb-show-9-10-25-jvdbtmomx9glnk7xwo0x Please read this disclaimer carefully before you (“you”, “your”) use our [Your Website URL] website (“website”, “service”) operated by the [Your Business Name] (“operator”, “us”, “we”, “our”). Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.
This week, Shawn Wilkie and Dr. Ivan Zak welcome Alex Voda from The Cat Health Company to discuss how the startup became the first clinical-stage company focused on feline longevity. Alex explains why cats are better models than other species for pharmaceutical R&D and how repurposing existing drugs could accelerate new treatments. He shares insights into why longevity companies still move slowly, highlights common and unique feline aging mechanisms, and reflects on what these innovations could mean for veterinarians, pet owners, and the broader future of veterinary practice. Learn more about The Cat Health Company. Alex recommends Youtube - Alex Zhavoronkov at ARDD2024: Methylation Clocks and AI Life Models as Sources of Therapeutic Target.
In our last two episodes we discussed the impact of U.S. policy shifts on global FDA-regulated products supply chain and shared industry perspectives on global supply chain disruptions. On today's episode, we unpack the sweeping tax reforms introduced by the One Big Beautiful Bill Act signed into law on July 4, 2025. With major changes to R&D expensing, international tax regimes, and incentives for domestic manufacturing, the bill is poised to reshape the global pharmaceutical supply chain. We explore how these provisions affect multinational pharma companies' supply chain strategies.Winston Kirton – wkirton@bakerlaw.com Brian Davis – bdavis@bakerlaw.com
Aaron McIntire unpacks the chilling details of Iryna Zarutska's murder on Charlotte's light rail, with President Trump and local officials condemning soft-on-crime policies. Violent protests erupt in Nepal over governance and social media bans, while RFK Jr. targets Big Pharma's TV ads. Plus, an Aaronalysis reveals the nihilistic motives behind George Soros' push for lenient district attorneys. Charlotte murder, Irina Zaruzka, soft-on-crime policies, Trump, Nepal protests, RFK Jr., pharmaceutical ads, George Soros, demoralization, vaccines
Trump’s alignment with the tech fascists is expanding as evidenced b y his recent meeting with Bill Gates, Mark Zuckerberg and a who’s who of technocratic oligarchs. They are salivating over the reset of global power structures and Trump just might be the guy to help them realize their malignant power heist. Digital control grids are being rolled out across the globe via digital ID and social credit scoring systems in places like China, Vietnam and the outcomes have been devastating for humanity. The regular folks are revolting, opting for barter and cash but that’s not stopping Trump and the techno-fascists here in America. We’ll take a look at what life is like under techno-fascism and talk about how we can resist them here. If China can effectively resist, so can WE! Also today - are you going to fall for Trump’s latest Rope-a-Dope? He posted a video condemning ALL VACCINES as poison because of thimerosal contamination and MAGA is celebrating because they think he has finally seen the light. I see it as a MASSIVE scam on behalf of PHARMA and I’ll explain that in detail today. WATCH LIVE HERE: https://rumble.com/c/TheShannonJoyShow GOLD WATCH: The gold market remains supported by ongoing geopolitical tensions, shifting U.S. monetary policy expectations, and strong central bank and investor demand. It NOT too late to protect your wealth and even thrive in a down economy with gold and silver. Colonial Metals Group is the company I trust! Click HERE www.colonialmetalsgroup.com/joy to get started and see if you qualify for $7500 in free silver. Shannon’s Top Headlines September 9, 2025: Could Trump Trigger The Globalist Great Reset? https://www.technocracy.news/could-trump-end-up-triggering-the-globalist-great-reset/ Bill Gates - Next Generation Vaccines: https://x.com/HustleBitch_/status/1963763440641622274 Dethroning Big Brother: China's Social Credit Rebellion Goes Viral: https://open.substack.com/pub/reinettesenumsfoghornexpress/p/dethroning-big-brother-chinas-social?r=fuu7w&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false Sasha Latypova Atomic Truth Bomb: https://x.com/SenseReceptor/status/1964208572025417981 It’s WORSE Than You Imagine China’s Disastrous Rollout Of The Digital Yuan https://youtu.be/ZJ5qUv9sqcU You Will Own Nothing - Not Even A House. Homebuilders Selling Entire Neighborhoods For RENTALS: https://www.technocracy.news/debt-based-capitalism-is-over-gives-way-to-asset-based-system/ No, Trump IS NOT Going To War With Vaccines: https://x.com/ShannonJoyRadio/status/1965140685860028920 SJ Show Notes: Sign up for Shannon’s daily E-blast at www.theshannonjoy.com Please support Shannon’s independent network with your donation HERE: https://www.paypal.com/donate/?hosted_button_id=MHSMPXEBSLVT Support Our Sponsors: Finally get a great nights sleep with absolutely zero risk! Perfect Origins is offering a risk-free 180‑day guarantee. Time to reclaim your sleep. Go to https://www.perfectorigins.com/perfectsleep/sjs.html Creatine is NOT just for body builders and muscle heads! It’s GREAT for women too and it’s why the whole Joy clan uses Native Path Creatine every day. Claim their EXCLUSIVE 56% off deal before it’s gone. Go to www.savewithnativepath.com/joy Thank you to The Satellite Phone Store for helping America to be independent AND prepared! The Satellite Phone Store has EVERYTHING you need when the POWER goes OUT. Use the promo code JOY for 10% off your entire order TODAY! www.SAT123.com/Joy The best medicine is chronic GOOD health and achieving it naturally. It’s why my family uses Native Path Creatine every day! Go to www.savewithnativepath.com/joy today to claim your EXCLUSIVE 56% off deal before it’s gone. Please consider Dom Pullano of PCM & Associates! He has been Shannon’s advisor for over a decade and would love to help you grow! Call his toll free number today: 1-800-536-1368 or visit his website at https://www.pcmpullano.com
The Boys In Gold travled to Huntsville this week for their annual Space Cowboy derby. Clay and Valair also take time to answer some important questions. Thanks for all your support!
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Novartis recently acquired Tourmaline for $1.4 billion, continuing its investment in cardiovascular treatments. The company has also made other partnerships in the cardiovascular space this year. Biogen is preparing to release new data on its lupus treatments, with analysts praising the company's pipeline. Novartis has been active in mergers and acquisitions, putting over $17 billion into deals this year. The biotech industry is also seeing some activity, with LB filing for a $228 million IPO to support its phase III plans. Overall, companies like Novartis and Biogen are focusing on expanding their portfolios and developing innovative treatments for various diseases.
Send us a textDo you ever find yourself replaying conversations in your head after a meeting?Second-guessing your words…shying away from conflict…feeling like something invisible is holding you back from truly fulfilling your leadership potential?Maybe, on top of your demanding role, you're balancing everything else raising children, caring for aging parents, trying to prioritise your health, or even, like one of today's guests, navigating a life-changing medical challenge.Want to Lead with More Confidence and Live with More Balance? Discover 3SIXTY leaders ClubPodcast Details: In this weeks' episode of the 360 LeadHERship Podcast, I'm joined by two phenomenal 3SIXTY Leaders Club members, Avril Whitty and Danielle Buggel who share their raw, honest journeys from self-doubt and overthinking to confident, strategic leadership. Their stories prove that you can thrive in senior leadership and make time for the moments that matter most without burning out or losing yourself in the process.Their journeys are proof that you can rise to the top without burning out or sacrificing your personal life. When you invest in yourself and surround yourself with the right support, you unlock the clarity, confidence, and calm you need to lead with impact and still have the time and energy to enjoy your life.Tune in to discover:The powerful mindset shifts Avril and Danielle made to create more space, balance, and joy in their day-to-day lives.The role 3SIXTY Leaders Club played in accelerating their confidence, clarity, and career progressionWhy visibility is key to building executive presence (and how to start showing up more powerfully).How to embrace fear, take action before you feel “ready,” and use group coaching to fast-track your results.What it really takes to overcome reservations about investing in yourself and why it's the smartest move you'll ever make.Recommended Next Steps
Hidradenitis suppurativa (HS) is, by all accounts, a painful disease.An estimated 3 million Americans live with HS, which is most commonly identified by flare ups as well as painful and unflattering lumps under the skin.Over the past few years, drugmakers have launched campaigns and marketing efforts to bring greater attention and understanding to the disease.Recently, Incyte launched HS Truths – an educational campaign to shine a spotlight on the physical symptoms of the disease as well as the associated mental health challenges.Patient-led, HS Truths provides insights into how frustrating it can be to live with the disease before receiving a proper medical diagnosis – which occurs after an average of seven to 10 years.This week, Managing Editor Jack O'Brien is joined by Stephenie Atkins, senior director, brand lead product strategy and marketing at Incyte, to discuss HS Truths and how it serves to elevate the profile of HS as a disease state.And for our Trends segment, we're talking about all things related to the continued splintering of vaccine policy uniformity in America under Robert F. Kennedy Jr.'s leadership at HHS.Music: “Deep Reflection” by DP and Triple Scoop Music. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.
This episode is sponsored by Invivyd, Inc.Marc Elia is a biotech investor, the Chairman of the Board at Invivyd, and a Long COVID patient who decided to challenge the system while still stuck inside it. He's not here for corporate platitudes, regulatory shoulder shrugs, or vaccine-era gaslighting. This is not a conversation about politics, but it's about power and choice and the right to receive care and treatment no matter your condition.In this episode, we cover everything from broken clinical pathways to meme coins and the eternal shame of being old enough to remember Eastern Airlines. Marc talks about what it means to build tools instead of just complaining, what Long COVID has done to his body and his patience, and why the illusion of “choice” in healthcare is a luxury most patients don't have.This conversation doesn't ask for empathy. It demands it.RELATED LINKSMarc Elia on LinkedInInvivyd Company SiteMarc's Bio at InvivydFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of the AI in Business podcast, host and Emerj Editorial Director Matthew DeMello speaks with Yunke Xiang, Global Head of Data Science for Manufacturing, Supply Chain, and Quality at Sanofi. Together, they examine how generative AI and reasoning models are evolving from simple automation to high-impact copilots across pharmaceutical operations. Yunke shares examples of how AI is enabling “talk to your data” use cases, automating regulatory reporting, and accelerating knowledge transfer for new employees. He also highlights how agentic AI systems may soon extend beyond copilots to function as digital teammates, orchestrating tasks across complex supply chains and ERP migrations. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Send us a textMark Menning, PhD, pharmaceutical scientist and founder of MARK Los Angeles, joins Lara Schmoisman to unpack how flavonoids, clinical trials, and advanced delivery systems are reshaping skincare. From FDA-approved antivirals to cold sore serums and acne care, he shares how science—not hype—is driving the next era of beauty and wellness.We'll talk about:Why drug delivery—not just ingredients—defines whether skincare worksHow a career in pharma led to groundbreaking skincare innovationsThe role of flavonoids as powerful anti-inflammatory and antiviral activesLessons from running full clinical trials in an industry that avoids themWhy consumer feedback forced MARK Los Angeles to reposition products—and why it workedHow inflammation became the “enemy” driving premature aging and poor skin healthWhat the future of beauty looks like when science—not marketing—sets the standardFor more information, visit Mark Menning's LinkedIn.Subscribe to Lara's newsletter.Also, follow our host Lara Schmoisman on social media:Instagram: @laraschmoismanFacebook: @LaraSchmoismanSupport the showSupport the show
Brandon is off and David is by himself for a quick podcast covering inflation, holiday outlook, tariff refunds and why he got Bullish wrong and lost money.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A new data release shows that Summit's Keytruda competitor, Ivonescimab, had better overall survival rates in Asian patients compared to those in North America and Europe. Despite this, the drug narrowly missed the statistical significance threshold required by the FDA for approval in Western countries. Meanwhile, Rapport Therapeutics saw a 180% increase in its stock value after positive mid-stage data for its epilepsy pill, and the FDA opted for a consumer "green list" instead of addressing compounded versions of obesity drugs. The FDA's leadership turnover has led to confusion and uncertainty for small and medium biopharma companies. Lilly is seeking individuals who are willing to challenge the status quo in medicine.FDA expert panels are being criticized for lack of balance, with some meetings being one-sided. RFK Jr. faced bipartisan criticism for his anti-vaccine views during a Senate hearing. Meanwhile, Servier committed up to $530 million in an eye cancer deal and Gilead partnered with the US State Department to distribute a drug to low-income countries. The FDA released a new rare disease approval framework and dropped heavily redacted rejection letters. Amidst uncertainty in FDA leadership, small and medium biopharma companies are left without clear guidance for their therapies. Opinion pieces highlight the potential of small molecules in gene therapy for Duchenne muscular dystrophy and criticize the lack of balance in FDA expert panels. The newsletter also includes upcoming events, job listings, and a request for feedback on coverage topics.
Managing editor Jack O'Brien talks with medical marketer turned mental health warrior Jon Nelson and neuroscientist Dr. Rachel Wurzman about their consulting firm NeuroLivd.The organization is dedicated to infusing lived experience perspectives into the mental health, wellness and neurological space – fueled by their passion and substance as well as rooted in their own deep lived experience within these conditions. Music - Mark Buergler - On The Run (Instrumental), Triple Scoop Music Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.
When it comes to breaking down barriers, humour is vitally important, helping to do away with stigma when it comes – in particular – to pharma and health advertising. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Coane, health partner at creative agency Leith, who talks sensitivity, maximum impact, and overcoming the fear of getting it wrong. After all, dull ads can lead to the dreaded ‘beige tax'. You can also listen to episode 204a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
In this inspiring episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Fabrizio “Fab” Mancini—internationally recognized chiropractor, educator, speaker, and author of Self-Health. Together, they unpack the failings of a profit-driven healthcare system and reveal how true healing begins with personal responsibility, lifestyle choices, and reconnecting to the body's innate ability to heal.From his transformative car accident in the 1980s to becoming the youngest university president in the U.S., Dr. Mancini shares why he chose chiropractic over surgery, how the medical establishment actively suppressed natural approaches, and why integrative medicine and biohacking are changing the conversation on chronic disease.This episode is a wake-up call for anyone navigating chronic illness, questioning conventional care, or seeking the tools to live with vitality into their 90s and beyond.In This Episode, You Will Learn:How a devastating car accident led Dr. Mancini to chiropractic careThe truth about medical education vs. chiropractic educationWhy pharmaceuticals fail in chronic disease—and what really worksThe three chiropractic principles that shaped Dr. Mancini's lifeHow government subsidies fuel chronic illnessWhy childhood obesity and infertility are on the rise—and what parents can doWhat “biohacking” really means and why it's not just for the wealthyHow Self-Health empowers anyone to prevent and reverse disease
In Vivo spoke with Annette Bakker, CEO of the Children's Tumor Foundation, a medical research foundation developing an innovative approach to reviving shelved pharmaceutical assets, resulting in the recent US FDA approval of mirdametinib, a treatment for rare tumors.
As statisticians in pharma, one of the most important professional relationships we can build is with our physician colleagues. When this partnership works well, studies run smoother, decisions are better, and our impact for patients grows. In this all-time Top 7 replay, Benjamin Piske and I talk about what makes this collaboration effective, the challenges you may face, and how to establish yourself as a true partner rather than “just the statistician.”
Physician-turned-politician Abdul El-Sayed joins Chuck Todd to discuss why he left medicine for the rough-and-tumble of politics. From the challenges of running for office with a foreign name to centering his campaign on improving life for children, El-Sayed argues that healthcare isn't just about access—it's about fairness. He pulls back the curtain on a system where insurers and hospital CEOs collude to inflate prices, pharmaceutical companies raise costs simply because they can, and Americans are tricked into thinking “choice” in healthcare actually benefits them.The conversation doesn't stop at healthcare—it spans the crisis of trust in public health, the lessons El-Sayed learned from his 2018 gubernatorial run, and the corrosive role of money in politics. He weighs in on Gretchen Whitmer's record, Trump's overreach beyond Article II, and what sets him apart in Michigan's Senate race. And in a moment of global reflection, El-Sayed takes on the politics of genocide—from Israel and Gaza to China's treatment of the Uighurs—arguing that calling atrocities by their name is a test of values, even when nuance is hard to find in today's polarized climate.Timeline:00:00 Abdul El-Sayed joins the Chuck ToddCast01:45 What made you choose politics when your background is medicine?03:30 The challenge of running for office with a foreign name04:30 Centering politics around improving the world for children05:30 Disparities in access to health care based on money and connections07:00 Health insurance is getting worse despite rising cost08:15 Insurers and hospital CEOs collude to raise prices10:15 What should be the cost expectation for pharmaceuticals?11:45 Pharma companies raise prices because they can12:45 RFK Jr. shouldn't be anywhere near healthcare13:45 The impact of the internet on public health15:45 The crisis Kennedy is creating at HHS and CDC16:30 How can we restore trust in public health authorities?18:45 MAHA's appeal is the idea you can control your health future20:00 Parallels between public health and education21:45 Health relies on both the individual and public health22:45 Healthcare industry has tricked the public using concept of “choice”24:30 Would you keep a semi-privatized system under medicare for all?27:00 Health networks curtail choice and raise prices28:30 What did you learn from your 2018 run for governor?31:00 The disease of our political system is money buying politicians and policy32:15 Trump spoke to economic pain and was able to reach voters33:45 Assessment of Gretchen Whitmer's governorship35:45 Whitmer tried to work with Trump at times, will you?37:45 Trump is exercising far more power than Article 2 permits39:30 Differences between you and your opponents for MI senate?40:15 Taking corporate money is a major philosophical difference42:45 Reforming public health will require healthcare pros in D.C.44:30 The trend of public health officials running for office46:45 How much will Israel/Gaza factor into the election?48:00 Calling something a genocide when you see it is a values test49:15 Was Israel justified in going after Hamas? How much was justifiable?50:15 The extremes on both sides of the war strengthen each other51:15 We aim, arm and abet Israeli leaders who don't want two states52:15 Tax dollars should benefit taxpayers, not foreign militaries53:15 It's difficult to find nuance in our current politics55:30 Money in politics make it difficult to have an honest conversation56:15 Having a nuanced conversation around the world genocide58:30 The holocaust can't set the bar for use of the term “genocide”1:00:00 Is China committing genocide of the Uighurs?1:01:15 Using the word genocide can just “switch off” voters1:03:30 People assume having an Arab name means tribal loyalty to Arabs
On this episode of the Chuck ToddCast, the conversation turns to the political battles shaping 2025. From the issues Democrats should lean into—and the ones they should avoid—to Trump's trolling of Chicago and his administration's push for a showdown over crime and “terrorism,” the stakes are high. Chuck dives into how the White House is setting the stage for possible military action against cartels and even Venezuela, with flimsy constitutional justifications that have sparked pushback from voices like Rand Paul. Meanwhile, Democrats face their own identity struggles, from the risks of being tied to “socialism” with Latino voters to Bernie Sanders' refusal to formally join the party. Plus, a look ahead to the Michigan Democratic Senate primary, where three strong contenders could reshape the party's futureThen, physician-turned-politician Abdul El-Sayed joins Chuck to discuss why he left medicine for the rough-and-tumble of politics. From the challenges of running for office with a foreign name to centering his campaign on improving life for children, El-Sayed argues that healthcare isn't just about access—it's about fairness. He pulls back the curtain on a system where insurers and hospital CEOs collude to inflate prices, pharmaceutical companies raise costs simply because they can, and Americans are tricked into thinking “choice” in healthcare actually benefits them.The conversation doesn't stop at healthcare—it spans the crisis of trust in public health, the lessons El-Sayed learned from his 2018 gubernatorial run, and the corrosive role of money in politics. He weighs in on Gretchen Whitmer's record, Trump's overreach beyond Article II, and what sets him apart in Michigan's Senate race. And in a moment of global reflection, El-Sayed takes on the politics of genocide—from Israel and Gaza to China's treatment of the Uighurs—arguing that calling atrocities by their name is a test of values, even when nuance is hard to find in today's polarized climate.Finally, Chuck gives a history lesson on Gerald Ford's pardon of Richard Nixon and its impact on modern politics, recaps the weekend in college football, and answers listeners' questions in the “Ask Chuck” segment.Timeline:(Timestamps may vary based on advertisements)00:00 Introduction04:00 The issues Democrats should run on, and issues they should avoid05:15 Trump's trolling of Chicago got the reaction he wanted06:30 The administration wants a showdown over Chicago08:30 The administration's aggressive application of the term “terrorism”10:15 The Democratic base wants fight, government shutdown likely12:15 Trump administration setting the stage for war with Venezuela13:30 Administration needs to justify designating cartels terrorists16:45 Trump's justification to congress for military action against cartels 19:00 Trump's justification was lacking, and didn't mention Venezuela 20:15 Trump ignoring the constitution in rationalizing action against cartels 21:45 Vance says fighting cartels is best use of military 23:15 JD gets into back and forth with Rand Paul on X 24:45 Venezuela story should be consuming Washington 26:15 Rand Paul has been willing to be combative with administration 29:00 The progressive left won't succeed if they're associated with socialism 30:45 "Socialism" isn't rebrandable with Latino voters 31:45 Bernie Sanders still hasn't joined the Democratic party 33:15 Michigan Democratic senate primary has 3 great candidates33:45 Abdul El-Sayed joins the Chuck ToddCast 35:30 What made you choose politics when your background is medicine? 37:15 The challenge of running for office with a foreign name 38:15 Centering politics around improving the world for children 39:15 Disparities in access to health care based on money and connections 40:45 Health insurance is getting worse despite rising cost 42:00 Insurers and hospital CEOs collude to raise prices 44:00 What should be the cost expectation for pharmaceuticals? 45:30 Pharma companies raise prices because they can 46:30 RFK Jr. shouldn't be anywhere near healthcare 47:30 The impact of the internet on public health 49:30 The crisis Kennedy is creating at HHS and CDC 50:15 How can we restore trust in public health authorities? 52:30 MAHA's appeal is the idea you can control your health future 53:45 Parallels between public health and education 55:30 Health relies on both the individual and public health 56:30 Healthcare industry has tricked the public using concept of "choice" 58:15 Would you keep a semi-privatized system under medicare for all? 1:00:45 Health networks curtail choice and raise prices 1:02:15 What did you learn from your 2018 run for governor? 1:04:45 The disease of our political system is money buying politicians and policy 1:06:00 Trump spoke to economic pain and was able to reach voters 1:07:30 Assessment of Gretchen Whitmer's governorship 1:09:30 Whitmer tried to work with Trump at times, will you? 1:11:30 Trump is exercising far more power than Article 2 permits 1:13:15 Differences between you and your opponents for MI senate? 1:14:00 Taking corporate money is a major philosophical difference 1:16:30 Reforming public health will require healthcare pros in D.C. 1:18:15 The trend of public health officials running for office 1:20:30 How much will Israel/Gaza factor into the election? 1:21:45 Calling something a genocide when you see it is a values test 1:23:00 Was Israel justified in going after Hamas? How much was justifiable? 1:24:00 The extremes on both sides of the war strengthen each other 1:25:00 We aim, arm and abet Israeli leaders who don't want two states 1:26:00 Tax dollars should benefit taxpayers, not foreign militaries 1:27:00 It's difficult to find nuance in our current politics 1:29:15 Money in politics make it difficult to have an honest conversation 1:30:00 Having a nuanced conversation around the world genocide 1:32:15 The holocaust can't set the bar for use of the term "genocide" 1:33:45 Is China committing genocide of the Uighurs? 1:35:00 Using the word genocide can just "switch off" voters1:42:45 Chuck's thoughts on interview with Abdul El-Sayed 1:44:15 This week in history - Chuck's history lesson 1:45:15 Gerald Ford pardoned Nixon on September 8th, 1974 1:47:00 The case for pardoning Nixon 1:49:15 The case against pardoning Nixon 1:52:00 Ford's decision implied the country couldn't handle a trial 1:53:15 A majority of the country thought the pardon was wrong 1:55:00 Nixon never got his due process 1:56:15 Pardon was a stain on presidential decision making 1:56:45 College football update 2:00:45 Ask Chuck 2:01:15 Why Putin won't grant Trump a ceasefire 2:04:15 Why do Epstein victims face dehumanization when Trump doesn't? 2:08:00 Thoughts on the political salience of this season of South Park?
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. During a Senate hearing, Robert F. Kennedy Jr. faced criticism for spreading anti-vaccine views and breaking promises regarding vaccines. The FDA released rejection letters for companies like Lykos Therapeutics, Stealth Biotherapeutics, and Regeneron. Ousted CDC director Susan Monarez accused Kennedy of firing her for not supporting Covid-19 recommendations from an advisory panel with "antivaccine rhetoric." Hengrui Pharmaceuticals signed lucrative deals with Merck and GSK, while the FDA promised to release future Complete Response Letters promptly. In other news, Sanofi's anti-OX40 blocker failed in a Phase III study, Gilead partnered with the US State Department for low-income countries, and AC Immune announced workforce cuts. Kennedy was accused of lying during the hearing, and the FDA released a new rare disease approval framework.
Send us a textIn this episode of the Life Science Success Podcast my guest is Nissan Cohen, a worldwide expert with over 45 years of experience in high purity water systems, pharmaceutical engineering, and water technology innovation. Nissan is the Owner of Biopharmaceutical Water Doc company and has made significant contributions to the field through his extensive publications, technical expertise, and leadership in international professional societies like ISPE.00:00 Introduction to Life Science Success Podcast 00:29 Meet Dr. Nissan Cohen: Water Technology Expert01:24 The Importance of Potable Water01:52 Journey into High Purity Water Systems03:32 Transition to Pharmaceutical Industry06:12 Milestones in Pharmaceutical Water Technology09:54 Current Consultancy and Industry Challenges14:32 Advancements in Pharmaceutical Water Technologies20:51 Sustainability and Zero Liquid Discharge29:22 Agricultural Water Innovations35:43 Leadership and Professional Insights41:23 Concerns and Future Outlook44:42 Conclusion and Final Thoughts
01:00:44 – RFK Jr. Torches Senate RFK Jr. clashes with senators, calling Maggie Hassan a liar and exposing CDC corruption. He slams pharma influence and cites data showing suppressed autism risks. 01:07:55 – Autism Cover-Up Exposed RFK Jr. details a 2002 CDC study showing black boys had a 260% higher autism risk with early MMR shots—data destroyed by officials to protect pharma. 01:11:10 – Cassidy Traps RFK Jr. Sen. Bill Cassidy forces RFK Jr. to endorse Trump's Operation Warp Speed, calling it Nobel-worthy. RFK caves, exposing his compromise with Trump's ego. 01:16:10 – Senators Bought by Pharma Discussion lists senators pocketing millions from vaccine makers: Warren, Sanders, Romney, Cassidy, and others. Both parties are shown as fully captured by pharma. 01:23:16 – Spike Protein = Bioweapon Listener analysis ties vaccine harms to spike protein's destruction of ACE2, fueling myocarditis, clotting, and turbo cancers. Critics call the jabs a Pentagon-DARPA bioweapon. 01:27:33 – Trump, Gates, and Zuckerberg Dinner Trump dines with Bill Gates and Mark Zuckerberg at the White House. Commentary frames it as proof Trump embraces technocrats pushing AI, depopulation, and new mRNA delivery systems. 01:51:24 – Tim Kaine: Rights From Government Sen. Tim Kaine claims rights come from government, not God—sparking outrage. Ted Cruz rebukes him with Jefferson's words, while critics tie Kaine's stance to Marxist liberation theology. 01:59:42 – Liberation Theology = KGB Ops Discussion traces Kaine's worldview to “liberation theology,” described as a KGB psyop to destabilize the West. Parallels are drawn to Pope Francis and modern Marxist infiltration in religion. 02:03:47 – DOJ Pushes Gun Ban for Transgender People DOJ considers labeling transgender individuals as mentally ill to strip gun rights. Critics warn it's a Trojan horse for red flag gun laws and Trump-style “due process later” policies. 02:07:47 – Trans Militancy & Socialist Rifle Association Zero Hedge report links trans shooters with the far-left Socialist Rifle Association, whose rainbow-AR-15 imagery echoes recent killings. Hosts warn conservatives are being baited into cheering gun control. 02:17:13 – Trump's Asylum Agenda Trump and Melania push reopening mental institutions and mandatory mental health screenings. Critics warn this echoes totalitarian regimes weaponizing psychiatry to silence dissent. 02:19:54 – John Rich vs. TVA Land Grab Country singer John Rich helps Tennessee locals fight the TVA's eminent domain scheme for a methane gas plant. After massive pushback, TVA cancels plans—framed as a rare grassroots victory against corporate-government overreach. 03:05:52 – Gold Soars on Weak Jobs Gerald Celente joins to discuss gold hitting $3,600 amid dismal job numbers. Weak labor markets signal looming rate cuts, sinking the dollar and driving investors to safe havens. 03:09:12 – Trump's Crypto Empire Exposed Discussion shifts to how Trump's family quietly moved massive wealth into Bitcoin and crypto mining. His stake is now larger than his global resorts, raising conflict-of-interest concerns. 03:12:54 – Dragflation & Debt Heart Attack Celente predicts “dragflation”—declining growth plus surging inflation—as debt tops $220 trillion. Ray Dalio's warning of a “debt-induced heart attack” within three years is echoed as inevitable. 03:14:42 – Gold Goes Digital The World Gold Council prepares to tokenize bullion for global trading. Analysts warn it could wipe out unstable cryptocurrencies and challenge U.S. dollar dominance. 03:26:02 – H-1B Scam & Cheap Labor Conversation turns to H-1B visas, tracing back to Bill Clinton and expanded under Trump and Biden. Both parties are accused of flooding the U.S. with cheap foreign labor to suppress wages. 03:36:02 – Venezuela Strike = Oil Grab Trump's shoot-first policy in Venezuela is blasted as a false “drug war” pretext to seize oil. Comparisons are drawn to Duterte's Philippines and past regime-change coups. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.
GET A BOOK! https://amzn.to/481ICEy SEND STUFF! 9170 Glades Road, PO Box #139, Boca Raton, Florida, 33434 GIT SUM MECH! https://vivafrei.com/
Liz Warren is calling for RFK Jr. to resign as Secretary of Health & Human Services. He's right, though. She took over $800,000 dollars of PAC money on behalf of Pharmaceutical companies.
In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam's journey from academic to commercial, and what helped him transition into 'life science enablers". How pandemic demand has left our sector with a huge over capacity issue and market imbalance. Some positive signals for the second half of 2025 after a period of geopolitical chaos, and a bumpy rollercoaster. Even thought biotech funding has largely returned... how decreasing clinical trials, a shifting of therapeutic focus, and the concentration of investments on fewer, higher value deals is impacting pharma services. The value of building a reputation in one in-demand modality area before extending into other modalities. And why the CDMO is at an inflexion point... Adam is a Managing Director and Partner in L.E.K. Consulting's New York office and a member of the Life Sciences practice. He has been with L.E.K. for over eight years, and has experience across diagnostics and research tools, bioprocessing and pharma services, and emerging, mid-cap and large pharma. Adam has helped a number of clients in the life sciences industry with growth strategy, life cycle management, portfolio optimization and M&A projects. Adam holds a Bachelor of Science from Boston College and a Ph.D. from the Perelman School of Medicine at the University of Pennsylvania. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.
Bizable https://GoBizable.comUntie your business exposure from your personal exposure with BiZABLE. Schedule your FREE consultation at GoBizAble.com today. Renue Healthcare https://Renue.Healthcare/ToddRegister today to Join the Renue Healthcare Webinar Thursday September 11th at 11:00 PST. Visit https://joinstemcelltalks.com or call 602-428-4000. Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/toddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeBig Pharma and the Mockingbird Media have been peddling things for years. Don't believe me? Let's go over some of the ways big industries have infiltrated our media in the past…Episode Links:EXPOSED! Those Crazy Food Guidelines Saying Cereal Is Better Than Beef Are Total FraudFlintstones Winston Cigarettes Commercial (Rare)Influencers mock Jesus Christ to sell weight loss drugBeverly Hillbillies - Cast Ad #03 - Winston CigarettesPfizer Commercial (2023) 'Got Booster ?' Featuring Travis KelceWorld War Z Official Movie TrailerThe Girl With All The Gifts – Official Trailer - Official Warner Bros. UKDr Paul Offit: RFK Jr's vaccine stance making it a 'dangerous time to be a child'RFK, Jr,. on one example of the financial corruption of the NIH, CDC and FDA15 Mr. Magoo Beer Commercials | HD Upscaled & Enhanced Audio
Sincere question. At a minimum - who in government is actively trying to improve the life, liberty, and pursuit of happiness for Americans? It would be impossible to say Democrats. Whether they're fighting President Trump on deporting illegal alien criminals, developing more energy sources, reducing crime in our major cities, or challenging Big Food and Pharma to make Americans healthy again - Democrats simply can't abide Trump success. Meanwhile, the President assures everyone yesterday he's alive and well as he moves the Space Force, blows Venezuelan drug cartels out of the water (literally), and pledges to fight activist judges on his tariffs to save the country economically. We get into the law surrounding tariffs and other matters with Mark Weaver. John Hayward from Bretibart discusses the eyebrow raising meeting between Inda, China, and Russia. And meet a candidate and former judge taking on a Soros-backed DA in Philadelphia. -For more info visit the official website: https://chrisstigall.comInstagram: https://www.instagram.com/chrisstigallshow/Twitter: https://twitter.com/ChrisStigallFacebook: https://www.facebook.com/chris.stigall/Listen on Spotify: https://tinyurl.com/StigallPodListen on Apple Podcasts: https://bit.ly/StigallShowSee omnystudio.com/listener for privacy information.
Turn online alignment into an offline community — join us at TheWayFwrd.com to connect with like-minded people near you. It's the best way to support this podcast and the movement we're building together: https://thewayfwrd.com/join/ Dr. Lori Earley joins Alec for a conversation on her journey from pharmaceutical sales to becoming a doctor of Chinese medicine. She shares what she witnessed in the drug industry, from downplaying side effects to the promotion of adult ADHD, and how those experiences led her to question modern healthcare. They discuss her pivot into acupuncture and holistic medicine, the unexpected influences that guided her path, and the role of nutrition, intuition, and alternative healing in restoring health. For more details, links, timestamps and resources mentioned in this episode, visit our website: https://thewayfwrd.com/content/ LInks Website: www.phoenixrisingacu.comEmail: lori@phoenixrisingacu.com Instagram: instagram.com/phoenixrisingmedicine Special Offer: Listeners who work with Lori for a minimum of 4 months receive 15% off services and labs with code PRIM15 or mention to the scheduler that you heard about this through The Way Forward Podcast. Related Links & References Video from Dr. Marizelle Arce (Instagram): https://www.instagram.com/reel/DMLgSidu8j3/?igsh=MTFhb3kxcDl2eDg3Zw== Spark in the Machine by Dr. Dan Keown: https://www.drdankeown.com/books Fast Like a Girl by Dr. Mindy Pelz: https://www.amazon.com/Fast-Like-Girl-Healing-Hormones/dp/1401969925 Say Goodbye to Illness by Dr. Devi Nambudripad: https://www.amazon.com/Say-Good-Bye-Illness-Devi-Nambudripad/dp/0970434480 Phoenix Rising Online Health Meetings: https://phoenixrisingacu.janeapp.com/#/list Special Offer: Listeners who work with Lori for a minimum of 4 months receive 15% off services and labs with code PRIM15 or mention to the scheduler that you heard about this through The Way Forward Podcast. The Way Forward podcast is sponsored by: New Biology Clinic: Experience individually tailored terrain-based health services with virtual consults, practitioner livestreams, movement classes, and more. The New Biology Clinic's motivation is to make you healthy and keep you that way. Visit https://NewBiologyClinic.com and enter code TheWayForward for $50 off your activation fee. Members of The Way Forward get the full activation fee waived. Become a member of The Way Forward here: https://thewayfwrd.com/membership-sign-up/ ————————— Bioptimizers: Struggling with deep sleep? Magnesium deficiency might be the culprit. Try Magnesium Breakthrough with all 7 forms of magnesium for better rest. Use promo code ALEC10 at bioptimizers.com/alec for 10% off!